Letrozole vs. placebo after adjuvant tamoxifen in postmenopausal breast cancer: the MA-17 study
Gori, S.; Anastasi, P.; Marrocolo, F.
I Suppli di Tumori Official Journal of Societa Italiana di Cancerologia . 3(4): S27-S31
2004
ISSN/ISBN: 2283-5423 PMID: 15206206 Document Number: 9274
Per meglio comprendere le problematiche suscitate dalla pubblicazione dei risultati dello studio Ma-17 e per cercare dì valutarne le ripercussioni nella pratica clinica, è necessario fare una breve panoramica riassuntiva relativa: ai risultati ottenuti con il tamoxifene in adiuvante: al tipo di studi attualmente in corso con gli antiaromatasici in postmenopausa: ai risultati attualmente disponibili.
Document emailed within 1 workday
Related Documents
Novoa Vargas, A.; Font López, K.C.; Amador, D.D. 2011: Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer Ginecologia y Obstetricia de Mexico 79(9): 553-557Yoshida, M.; Saji, S.; Takagi, H.; Takeuchi, S.; Tsuda, H.; Nimura, Y.; Mizumoto, R.; Miyazaki, I.; Kobayashi, S.; Noguchi, M. 1993: A comparative study among ftorafur, ftorafur plus tamoxifen, and tamoxifen in adjuvant therapy for breast cancer. the Chubu Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2325-2333
Machin, D.; Andersen, K.W. 1997: Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer Journal of the National Cancer Institute 89(9): 659-660
Bardi, M.; Arnoldi, E.; Pizzocchero, G.; Pezzica, E.; Mattioni, D.; Perotti, M. 1994: Endometrioid carcinoma in pelvic endometriosis in a postmenopausal woman with tamoxifen adjuvant therapy for breast cancer. A case report European Journal of Gynaecological Oncology 15(5): 393-395
Tsukagoshi, S. 2006: Introduction of new drug: letrozole, a new non-steroidal aromatase inhibitor for the treatment of postmenopausal women with breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(6): 859-863
Sinawat, S.; Chiyabutra, T. 2004: Endometrial thickening in postmenopausal breast cancer patients taking tamoxifen: a cross-sectional study Journal of the Medical Association of Thailand 87 Suppl. 3: S59-S63
Sinawat, S.; Chiyabutra, T.; Kleabkaew, P. 2001: Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report Journal of the Medical Association of Thailand 84(7): 1033-1036
Baldini, B.; Taddei, G.L.; Tiso, E.; Visioli, C.B.; Campos, K.J.; Napolitano, A.C.; Tantini, C. 1996: Hysteroscopic evaluation of the endometrium in 63 postmenopausal patients treated with tamoxifen for breast cancer Minerva Ginecologica 48(6): 259-262
Bhatavdekar, J.M.; Shah, N.G.; Patel, D.D.; Karelia, N.H.; Trivedi, S.N.; Vora, H.H.; Ghosh, N.; Giri, D.D.; Balar, D.B. 1992: Endocrine function in premenopausal and postmenopausal advanced breast cancer patients treated with CMF or tamoxifen Neoplasma 39(2): 123-127
Elhelw, B.; Ghorab, M.N.; Farrag, S.H. 1999: Saline sonohysterography for monitoring asymptomatic postmenopausal breast cancer patients taking tamoxifen International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 67(2): 81-86
Semiglazov, V.F.; Maximov, S.Y.; Bulgatova, Y., A.; Meshkova, I.Y.; Chepik, O.F.; Berstein, L.M. 2003: Risk of hyperplasia and endometrial carcinoma in breast cancer patients receiving adjuvant tamoxifen Voprosy Onkologii (Stsburg). 49(2): 198-204
Dominick, S.; Hickey, M.; Chin, J.; Su, H.I. 2015: Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen Cochrane Database of Systematic Reviews 12: Cd007245
Marshall, J.S.; Gordon, N.H.; Hubay, C.A.; Pearson, O.H. 1987: Assessment of tamoxifen as adjuvant therapy in stage Ii breast cancer: a long-term follow-up Journal of Laboratory and Clinical Medicine 109(3): 300-307
Gershanovich, M.L.; Garin, A.M.; Baltinia, D.; Kurvet, A.; Kangas, L.; Ellmen, I. 1997: Results of phase Ii clinical trial of Tamoxifen and Toremifen in two different doses in advanced breast cancer in postmenopausal women Voprosy Onkologii 43(6): 587-595
1988: Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women New England Journal of Medicine 319(26): 1681-1692
Nesković-Konstantinović, Z.; Filipović, S. 2003: The role of endocrine therapy in early breast cancer: adjuvant treatment of preand postmenopausal patients Journal of Buon: Official Journal of the Balkan Union of Oncology 8(1): 11-17
Sharma, D.; Sharma, U.; Bhatnagar, V.B.; Singh, V.S. 2001: A study of the effect of tamoxifen on serum lipoprotein profiles in premenopausal and postmenopausal women with breast carcinoma and associated risk of cardiovascular disease Indian Journal of Medical Sciences 55(7): 359-365
Chiesa, M.Dalla.; Passalacqua, R.; Michiara, M.; Franciosi, V.; Di Costanzo, F.; Bisagni, G.; Camisa, R.; Buti, S.; Tomasello, G.; Cocconi, G. 2007: Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial Acta Bio-Medica: Atenei Parmensis 78(3): 204-209
Lindahl, B.; Andolf, E.; Ingvar, C.; Ranstam, J.; Willén, R. 2008: Adjuvant tamoxifen in breast cancer patients affects the endometrium by time, an effect remaining years after end of treatment and results in an increased frequency of endometrial carcinoma Anticancer Research 28(2b): 1259-1262
Crivellari, D. 2002: Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group Tumori 88(1 Suppl. 1): S81-S82